SYNformulas GmbH

PASSIONATE ABOUT GUT HEALTH

SYNformulas is one of the world's leading research-driven probiotics companies active in the field of gastrointestinal diseases and allergies. In cooperation with internationally recognized researchers and universities, the medium-sized company translates the latest scientific findings from microbiome research into visionary products. The innovative and evidence-based therapy options are marketed throughout Europe under the umbrella brand Kijimea®.

The acclaimed scientific standards, the high quality and stability of Kijimea® products help SYNformulas to achieve its international status as a global leader in probiotics.

MISSION

„Passionate about gut health – we unveil the power of the microbiome by developing & promoting break-through evidence-based probiotics that significantly improve patients‘ quality of life.“

VISION

As an employer of a new, dynamic generation, we have the courage to think big and take unconventional approaches. Our goal is to be a pioneer in microbiome research and make an important contribution to improve patients’ quality of life.

PRODUCTS

SYNformulas focuses on innovative OTC- products with scientifically proven effects. The product portfolio under the Kijimea® brand includes probiotics, medical devices, dietary supplements and food for special medical purposes and is marketed internationally.

Show all products

Kijimea® K53 is a dietary supplement containing 53 selected microculture strains found in the natural intestinal flora of humans. One pack of Kijimea® K53 contains 1 trillion microcultures.

In addition, Kijimea® K53 contains vitamin B12, which helps to reduce fatigue and tiredness and to promote normal function of the nervous system and biotin, which helps to maintain normal mucous membranes. Kijimea® K53 is vegan, contains no gluten, lactose or fructose.

Kijimea® K53 Advance contains a unique combination of 53 coordinated bacterial strains in a uniquely high dosage of over 1,500 billion CFU per pack.

To provide the bacteria contained an optimal breeding ground, Kijimea® K53 Advance also contains biotin, which contributes to the maintenance of normal mucous membranes.

X

The innovative medical product Kijimea® Regularis was specially developed for the treatment of constipation, sluggish digestion and a bloated belly. It contains the unique Synformularis2 fiber complex, which thanks to its special structure swells in the intestine and gently stretches the intestinal muscles.

This gives the intestines the impulse to move normally again - the intestines get going again under their own power.

X

Kijimea® Regularis PLUS contains methylcellulose and psyllium in a specific combination. Both ingredients belong to the so-called swelling agents - they swell in the intestine.

Kijimea® Regularis PLUS also contains over 300 million bacteria per serving from 6 selected bacterial strains. The bacteria were gently heat-inactivated in a complex process.

X

Kijimea® Liquid contains a unique nutrient complex of electrolytes and micronutrients in the form of effervescent tablets. 2 tablets are added to a glass of water. The specific composition allows the body to absorb significantly more liquid much faster.

X

The novel medical product Kijimea® Magen was developed specifically for the treatment of irritable stomach and symptoms such as stomach pain, bloating and nausea. Kijimea® Magen contains stomach-specific enzymes that break down the food pulp and thus relieve the stomach.

The active ingredient calcium carbonate, which is also contained, neutralizes excess stomach acid and thus protects the stomach from irritation.

X

Antibiotics can disturb the balance of the intestinal flora. The dietary supplement Kijimea® Synpro 20 contains 20 different, carefully selected strains of bacteria. These microcultures can settle in the intestine as part of the natural intestinal flora. In addition, Kijimea® Synpro 20 contains choline, FOS, inulin as well as biotin, which contributes to the maintenance of normal mucous membranes.

X

According to recent findings, a balanced intestinal mucosa plays a decisive role. Accordingly, a special combination of ten selected microcultures was developed for the dietary supplement Kijimea® Basis 10. These play an important role as part of the natural intestinal flora of humans.

In addition, Kijimea® Basis 10 contains choline and biotin, which contributes to the maintenance of normal mucous membranes - the breeding ground of the intestinal flora.

X

An imbalance in the intestinal flora is increasingly associated with irritations of the skin appearance.

Kijimea® Derma contains vitamins riboflavin and biotin, which contribute to the maintenance of normal skin. It also contains choline and the unique microculture L. salivarius FG01.

X

Around 70 percent of all immune cells are located in the intestine. This realization led to the development of the dietary supplement Kijimea® Immun.

Kijimea® Immun is a special combination of the specific microcultures L. rhamnosus LR 04, L. plantarum LP 02 and B. lactis BS 01 as well as FOS, choline, riboflavin and biotin. It additionally contains vitamin D to support the normal function of the immune system.

MILESTONES

2011
Launch of the blockbuster Kijimea® Irritable Bowel Syndrome
Study publication on the bifidobacterial strain exclusively contained in Kijimea® Irritable Bowel Syndrome
2015
Kijimea® Irritable Bowel is Product of the Year1
2017
Product launch Kijimea® Synpro 20
2018
Kijimea® Irritable Bowel was certified as "Highest Efficacy"2
Product launch Kijimea® Regularis
2019
Further development of the market leader Kijimea® Irritable Bowel to Kijimea® Irritable Bowel PRO

Product launch of Kijimea® K53 and Kijimea® Irritable Stomach

2020
Publication of the world's largest OTC irritable bowel study, The Lancet Gastroenterology and Hepatology

Become part of the FUTRUE family.
Become part of the FUTRUE family.

1 Online consumer survey in Germany in the period 13.05. - 06.07.2015, conducted by Q&A Research BV. A total of 4,522 ratings in 17 categories. Kijimea® Irritable Bowel was voted first place in the health category.

2 Kijimea® Irritable Bowel was awarded the rating "very good" for efficacy and tolerability in the category Stomach & Intestine a major German test. (Focus 23/18 v. 2.6.2018)